Global Bio-imaging Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027
Date: Apr-2021 | Id: MACRC-52716 | Geographical Scope: Global | Publisher: HNY Research
The global Bio-imaging market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). By Market Verdors: BioClinica Bracco Imaging FONAR Corporation Bayer HealthCare Covidien Digirad Corporation Esaote Hitachi Medical Gamma Medica GE Healthcare Positron Corporation Philips Healthcare SonoSite Siemens Healthcare Shimadzu Toshiba Medical Systems By Types: X-ray Radiography Medical Ultrasonography or Ultrasound Magnetic Resonance Imaging Elastography Other By Applications: Hospital Clinic Other Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Bio-imaging Revenue 1.5 Market Analysis by Type 1.5.1 Global Bio-imaging Market Size Growth Rate by Type: 2021 VS 2027 1.5.2 X-ray Radiography 1.5.3 Medical Ultrasonography or Ultrasound 1.5.4 Magnetic Resonance Imaging 1.5.5 Elastography 1.5.6 Other 1.6 Market by Application 1.6.1 Global Bio-imaging Market Share by Application: 2022-2027 1.6.2 Hospital 1.6.3 Clinic 1.6.4 Other 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Bio-imaging Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter’s Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Bio-imaging Market Players Profiles 3.1 BioClinica 3.1.1 BioClinica Company Profile 3.1.2 BioClinica Bio-imaging Product Specification 3.1.3 BioClinica Bio-imaging Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.2 Bracco Imaging 3.2.1 Bracco Imaging Company Profile 3.2.2 Bracco Imaging Bio-imaging Product Specification 3.2.3 Bracco Imaging Bio-imaging Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.3 FONAR Corporation 3.3.1 FONAR Corporation Company Profile 3.3.2 FONAR Corporation Bio-imaging Product Specification 3.3.3 FONAR Corporation Bio-imaging Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.4 Bayer HealthCare 3.4.1 Bayer HealthCare Company Profile 3.4.2 Bayer HealthCare Bio-imaging Product Specification 3.4.3 Bayer HealthCare Bio-imaging Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.5 Covidien 3.5.1 Covidien Company Profile 3.5.2 Covidien Bio-imaging Product Specification 3.5.3 Covidien Bio-imaging Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.6 Digirad Corporation 3.6.1 Digirad Corporation Company Profile 3.6.2 Digirad Corporation Bio-imaging Product Specification 3.6.3 Digirad Corporation Bio-imaging Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.7 Esaote 3.7.1 Esaote Company Profile 3.7.2 Esaote Bio-imaging Product Specification 3.7.3 Esaote Bio-imaging Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.8 Hitachi Medical 3.8.1 Hitachi Medical Company Profile 3.8.2 Hitachi Medical Bio-imaging Product Specification 3.8.3 Hitachi Medical Bio-imaging Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.9 Gamma Medica 3.9.1 Gamma Medica Company Profile 3.9.2 Gamma Medica Bio-imaging Product Specification 3.9.3 Gamma Medica Bio-imaging Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.10 GE Healthcare 3.10.1 GE Healthcare Company Profile 3.10.2 GE Healthcare Bio-imaging Product Specification 3.10.3 GE Healthcare Bio-imaging Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.11 Positron Corporation 3.11.1 Positron Corporation Company Profile 3.11.2 Positron Corporation Bio-imaging Product Specification 3.11.3 Positron Corporation Bio-imaging Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.12 Philips Healthcare 3.12.1 Philips Healthcare Company Profile 3.12.2 Philips Healthcare Bio-imaging Product Specification 3.12.3 Philips Healthcare Bio-imaging Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.13 SonoSite 3.13.1 SonoSite Company Profile 3.13.2 SonoSite Bio-imaging Product Specification 3.13.3 SonoSite Bio-imaging Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.14 Siemens Healthcare 3.14.1 Siemens Healthcare Company Profile 3.14.2 Siemens Healthcare Bio-imaging Product Specification 3.14.3 Siemens Healthcare Bio-imaging Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.15 Shimadzu 3.15.1 Shimadzu Company Profile 3.15.2 Shimadzu Bio-imaging Product Specification 3.15.3 Shimadzu Bio-imaging Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.16 Toshiba Medical Systems 3.16.1 Toshiba Medical Systems Company Profile 3.16.2 Toshiba Medical Systems Bio-imaging Product Specification 3.16.3 Toshiba Medical Systems Bio-imaging Production Capacity, Revenue, Price and Gross Margin (2016-2021) 4 Global Bio-imaging Market Competition by Market Players 4.1 Global Bio-imaging Production Capacity Market Share by Market Players (2016-2021) 4.2 Global Bio-imaging Revenue Market Share by Market Players (2016-2021) 4.3 Global Bio-imaging Average Price by Market Players (2016-2021) 5 Global Bio-imaging Production by Regions (2016-2021) 5.1 North America 5.1.1 North America Bio-imaging Market Size (2016-2021) 5.1.2 Bio-imaging Key Players in North America (2016-2021) 5.1.3 North America Bio-imaging Market Size by Type (2016-2021) 5.1.4 North America Bio-imaging Market Size by Application (2016-2021) 5.2 East Asia 5.2.1 East Asia Bio-imaging Market Size (2016-2021) 5.2.2 Bio-imaging Key Players in East Asia (2016-2021) 5.2.3 East Asia Bio-imaging Market Size by Type (2016-2021) 5.2.4 East Asia Bio-imaging Market Size by Application (2016-2021) 5.3 Europe 5.3.1 Europe Bio-imaging Market Size (2016-2021) 5.3.2 Bio-imaging Key Players in Europe (2016-2021) 5.3.3 Europe Bio-imaging Market Size by Type (2016-2021) 5.3.4 Europe Bio-imaging Market Size by Application (2016-2021) 5.4 South Asia 5.4.1 South Asia Bio-imaging Market Size (2016-2021) 5.4.2 Bio-imaging Key Players in South Asia (2016-2021) 5.4.3 South Asia Bio-imaging Market Size by Type (2016-2021) 5.4.4 South Asia Bio-imaging Market Size by Application (2016-2021) 5.5 Southeast Asia 5.5.1 Southeast Asia Bio-imaging Market Size (2016-2021) 5.5.2 Bio-imaging Key Players in Southeast Asia (2016-2021) 5.5.3 Southeast Asia Bio-imaging Market Size by Type (2016-2021) 5.5.4 Southeast Asia Bio-imaging Market Size by Application (2016-2021) 5.6 Middle East 5.6.1 Middle East Bio-imaging Market Size (2016-2021) 5.6.2 Bio-imaging Key Players in Middle East (2016-2021) 5.6.3 Middle East Bio-imaging Market Size by Type (2016-2021) 5.6.4 Middle East Bio-imaging Market Size by Application (2016-2021) 5.7 Africa 5.7.1 Africa Bio-imaging Market Size (2016-2021) 5.7.2 Bio-imaging Key Players in Africa (2016-2021) 5.7.3 Africa Bio-imaging Market Size by Type (2016-2021) 5.7.4 Africa Bio-imaging Market Size by Application (2016-2021) 5.8 Oceania 5.8.1 Oceania Bio-imaging Market Size (2016-2021) 5.8.2 Bio-imaging Key Players in Oceania (2016-2021) 5.8.3 Oceania Bio-imaging Market Size by Type (2016-2021) 5.8.4 Oceania Bio-imaging Market Size by Application (2016-2021) 5.9 South America 5.9.1 South America Bio-imaging Market Size (2016-2021) 5.9.2 Bio-imaging Key Players in South America (2016-2021) 5.9.3 South America Bio-imaging Market Size by Type (2016-2021) 5.9.4 South America Bio-imaging Market Size by Application (2016-2021) 5.10 Rest of the World 5.10.1 Rest of the World Bio-imaging Market Size (2016-2021) 5.10.2 Bio-imaging Key Players in Rest of the World (2016-2021) 5.10.3 Rest of the World Bio-imaging Market Size by Type (2016-2021) 5.10.4 Rest of the World Bio-imaging Market Size by Application (2016-2021) 6 Global Bio-imaging Consumption by Region (2016-2021) 6.1 North America 6.1.1 North America Bio-imaging Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Bio-imaging Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Bio-imaging Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Bio-imaging Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Bio-imaging Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Bio-imaging Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Bio-imaging Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Bio-imaging Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Bio-imaging Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Bio-imaging Consumption by Countries 7 Global Bio-imaging Production Forecast by Regions (2022-2027) 7.1 Global Forecasted Production of Bio-imaging (2022-2027) 7.2 Global Forecasted Revenue of Bio-imaging (2022-2027) 7.3 Global Forecasted Price of Bio-imaging (2022-2027) 7.4 Global Forecasted Production of Bio-imaging by Region (2022-2027) 7.4.1 North America Bio-imaging Production, Revenue Forecast (2022-2027) 7.4.2 East Asia Bio-imaging Production, Revenue Forecast (2022-2027) 7.4.3 Europe Bio-imaging Production, Revenue Forecast (2022-2027) 7.4.4 South Asia Bio-imaging Production, Revenue Forecast (2022-2027) 7.4.5 Southeast Asia Bio-imaging Production, Revenue Forecast (2022-2027) 7.4.6 Middle East Bio-imaging Production, Revenue Forecast (2022-2027) 7.4.7 Africa Bio-imaging Production, Revenue Forecast (2022-2027) 7.4.8 Oceania Bio-imaging Production, Revenue Forecast (2022-2027) 7.4.9 South America Bio-imaging Production, Revenue Forecast (2022-2027) 7.4.10 Rest of the World Bio-imaging Production, Revenue Forecast (2022-2027) 7.5 Forecast by Type and by Application (2022-2027) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027) 7.5.2 Global Forecasted Consumption of Bio-imaging by Application (2022-2027) 8 Global Bio-imaging Consumption Forecast by Regions (2022-2027) 8.1 North America Forecasted Consumption of Bio-imaging by Country 8.2 East Asia Market Forecasted Consumption of Bio-imaging by Country 8.3 Europe Market Forecasted Consumption of Bio-imaging by Countriy 8.4 South Asia Forecasted Consumption of Bio-imaging by Country 8.5 Southeast Asia Forecasted Consumption of Bio-imaging by Country 8.6 Middle East Forecasted Consumption of Bio-imaging by Country 8.7 Africa Forecasted Consumption of Bio-imaging by Country 8.8 Oceania Forecasted Consumption of Bio-imaging by Country 8.9 South America Forecasted Consumption of Bio-imaging by Country 8.10 Rest of the world Forecasted Consumption of Bio-imaging by Country 9 Global Bio-imaging Sales by Type (2016-2027) 9.1 Global Bio-imaging Historic Market Size by Type (2016-2021) 9.2 Global Bio-imaging Forecasted Market Size by Type (2022-2027) 10 Global Bio-imaging Consumption by Application (2016-2027) 10.1 Global Bio-imaging Historic Market Size by Application (2016-2021) 10.2 Global Bio-imaging Forecasted Market Size by Application (2022-2027) 11 Global Bio-imaging Manufacturing Cost Analysis 11.1 Bio-imaging Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Bio-imaging 12 Global Bio-imaging Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Bio-imaging Distributors List 12.3 Bio-imaging Customers 12.4 Bio-imaging Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer